APM
APM
NASDAQ · Biotechnology

Aptorum Group Ltd-Class A

$0.88
+0.08 (+10.27%)
As of Apr 1, 4:35 PM ET ·
Financial Highlights (FY 2025)
Revenue
3.16M
Net Income
-41,291
Gross Margin
56.6%
Profit Margin
-1.3%
Rev Growth
+21.0%
D/E Ratio
0.35
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 56.6% 56.6% 56.6%
Operating Margin -1.5% -1.6% -1.5%
Profit Margin -1.3% -1.6% -1.3%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 3.16M 3.05M 3.43M
Gross Profit 1.79M 1.73M 1.94M
Operating Income -48,331 -48,275 -52,202
Net Income -41,291 -50,098 -44,694
Gross Margin 56.6% 56.6% 56.6%
Operating Margin -1.5% -1.6% -1.5%
Profit Margin -1.3% -1.6% -1.3%
Rev Growth +21.0% -5.0% +24.8%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 776.3K 904.7K 890.0K
Total Equity 2.22M 2.33M 2.52M
D/E Ratio 0.35 0.39 0.35
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -71,807 -61,818 -76,890
Free Cash Flow -34,920 -36,621 -42,296